Autres langues Japan Tissue Engineering Co., Ltd.

Actions

7774

JP3389610001

Temps Différé Japan Exchange Autres places de cotation 04:30:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
719 ^JPY	+0,70 %		+3,30 %	+42,09 %

17/06	Japan Tissue Engineering Co. Ltd. annonce la soumission d'une demande d'approbation pour des modifications partielles du cartilage de culture autologue JACC annonce la soumission d'une demande d'approbation pour des modifications partielles du cartilage de culture autologue JACC	CI
30/04	Japan Tissue Engineering Co. donne des prévisions de résultats pour l'année se terminant le 31 mars 2025	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Japan Tissue Engineering Seeks Approval to Expand JACC Use for Knee Osteoarthritis	17/06
Japan Tissue Engineering Co., Ltd. Announces Submission of a Request of Approval for Partial Changes to Autologous Cultured Cartilage JACC	17/06
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2025	30/04
Japan Tissue Engineering Co., Ltd. Provide Earnings Guidance for the Fiscal Year Ending March 31, 2024	31/10/23
Japan Tissue Engineering Co., Ltd. Provide Earnings Guidance for the Fiscal Year Ending March 31, 2024	31/07/23
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2023	31/07/23
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024	27/04/23
Teijin, Japan Tissue Engineering to Team Up with Resilience US for Regenerative Medicine Technologies Development; Shares Climb 16%	21/04/23
Teijin Limited and Japan Tissue Engineering Co., Ltd. Form Business Alliance to Spur Development of New Regenerative Medicine Technologies	21/04/23
Japan Tissue Engineering Obtains Marketing Consent for Vitiligo Treatment	20/03/23
Japan Tissue Engineering Co., Ltd. Announces Marketing Approval for Autologous Cultured Epidermis Maintaining Melanocytes	17/03/23
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023	27/01/23
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2022	27/01/23
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended September 30, 2022	31/10/22
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023	31/10/22
Japan Index Adds Losses on Economic Uncertainty; Eisai Shares Skyrocket 17% on Favorable Results of Alzheimer's Drug	28/09/22
Teijin, Japan Tissue, Others to Put Medicine Platform; Japan Tissue Shares Fall 4%	28/09/22
Teijin, J-TEC, Mitsui Fudosan and NCC to Establish Regenerative Medicine Platform	27/09/22
Japan Tissue Engineering Concludes an Agreement with ActualEyes	08/08/22
Japan Tissue Engineering : Toward creation of a database for results of skin irritation tests using an alternative to animal testing	05/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Japan Tissue Engineering Co., Ltd.

Actions

7774

JP3389610001

Autres langues

Filtres